FMP

FMP

Enter

DERM - Journey Medical Corp...

Financial Summary of Journey Medical Corporation(DERM), Journey Medical Corporation focuses on the development and commercialization of pharmaceutical produ

photo-url-https://financialmodelingprep.com/image-stock/DERM.png

Journey Medical Corporation

DERM

NASDAQ

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

3.38 USD

-0.02 (-0.592%)

About

ceo

Mr. Claude Maraoui

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://journeymedicalcorp.com

exchange

NASDAQ

Description

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution....

CIK

0001867066

ISIN

US48115J1097

CUSIP

48115J109

Address

9237 East Via de Ventura Boule...

Phone

480 434 6670

Country

US

Employee

41

IPO Date

Nov 12, 2021

Summary

CIK

0001867066

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

48115J109

ISIN

US48115J1097

Country

US

Price

3.38

Beta

0.81

Volume Avg.

170.86k

Market Cap

67.37M

Shares

-

52-Week

1.02-8.11

DCF

4.79

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-16.1

P/B

-

Website

https://journeymedicalcorp.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest DERM News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep